New cord blood approach boosts survival in blood disease patients
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible…
Targeting glutamine metabolism enhances CAR-macrophage cancer therapy
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function. Specifically,…
Dutch study shows off-label targeted therapies benefit more cancer patients
The largest published prospective evaluation of off-label targeted cancer therapies has shown that more patients could benefit from…
Targeting senescent fat cells provides new hope for ovarian cancer
Ovarian cancer is the most lethal malignancy of the female reproductive system. Due to its insidious early symptoms…
Natural peptide PEPITEM shows promise in reducing arthritic joint swelling
Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable…
Nanomedicine offers targeted solutions for breast cancer treatment
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…
Fiber supplement stabilizes blood sugar in gestational diabetes
A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births…
Blood pressure drug boosts effectiveness of cancer therapy
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…
Scientists turn red blood cells into long-lasting drug and imaging carriers in mice
A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting…
New insights highlight multifaceted roles of CD4+ T cells in tumor immunity
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor…
Targeting IGF2BP2 improves anti-angiogenic therapy effectiveness in colorectal cancer
A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment…
Using engineered bacteria to breach tumor defenses
Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier…